Genome Editing in Engineered T Cells for Cancer Immunotherapy

Advanced gene transfer technologies and profound immunological insights have enabled substantial increases in the efficacy of anticancer adoptive cellular therapy (ACT). In recent years, the U.S. Food and Drug Administration and European Medicines Agency have approved six engineered T cell therapeut...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Human gene therapy Jg. 34; H. 17-18; S. 853
Hauptverfasser:	Bonini, Chiara, Chapuis, Aude G, Hudecek, Michael, Guedan, Sonia, Magnani, Chiara, Qasim, Waseem
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.09.2023
Schlagworte:	Anniversaries and Special Events B-Lymphocytes Gene Editing Humans Immunotherapy Neoplasms - genetics Neoplasms - therapy T-Lymphocytes United States United States CRISPR CAR TCR
ISSN:	1557-7422, 1557-7422
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!